Executive Spotlights

Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer

Oxford, UK, November 22, 2022 (Yahoo) -- Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy group, today announces the appointment of Dr Frank Mathias as Chief Executive Officer (CEO) and Board Director, effective March 2023.


Read full article here.

Recent Posts

See All
Life Science Headlines